4 latest FDA approvals

Here are the four latest drugs or medical devices approved by the Food and Drug Administration this week.

Advertisement

1. Vosevi is a follow-up treatment for adults with chronic hepatitis C virus genotypes 1 through 6 who have mild or no cirrhosis.

2. Nerlynx is a treatment for early-stage breast cancer patients with a HER2 genetic mutation.

3. Lusdana Nexvue is a biosimilar version of Sanofi’s diabetes drug Lantus.

4. The Embrace Neonatal MRI System is an MRI device for infants in the neonatal intensive care unit.

More articles on supply chain:

5 steps to reduce blood costs at your hospital
Bloomberg: FedEx’s TNT ‘may never fully recover’ from Petya attack
5 must-reads for supply chain leaders this week

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in Supply Chain

Advertisement

Comments are closed.